Membrane-Based Therapeutic Plasma Exchange in Intensive Care

https://doi.org/10.2215/CJN.04680513

2.

Williams

ME

,

Balogun

RA

.

Principles of separation: indications and therapeutic targets for plasma exchange

.

Clin J Am Soc Nephrol

.

2014 Jan

;

9

(

1

):

181

–

90

.

.

https://doi.org/10.1056/NEJM196009222631202

3.

Schwab

PJ

,

Fahey

JL

.

Treatment of Waldenstrom’s macroglobulinemia by plasmapheresis

.

N Engl J Med

.

1960 Sep 22

;

263

:

574

–

9

.

.

https://doi.org/10.1002/jca.20301

4.

Wehrli

G

.

Therapeutic apheresis instrumentation

.

J Clin Apher

.

2011

;

26

(

5

):

286

–

90

.

.

https://doi.org/10.1002/jca.21561

5.

Gashti

CN

,

Andreoli

DC

,

Patel

D

.

Membrane-based therapeutic plasma exchange (mTPE): technical and clinical experience

.

J Clin Apher

.

2018 Feb

;

33

(

1

):

38

–

45

.

.

6.

Padmanabhan

A

,

Connelly-Smith

L

,

Aqui

N

,

Balogun

RA

,

Klingel

R

,

Meyer

E

, et al.

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the writing committee of the American Society for apheresis: the eighth special issue

.

J Clin Apher

.

2019 Jun

;

34

(

3

):

171

–

354

.

https://doi.org/10.1007/BF01696619

7.

Pereira

A

,

Mazzara

R

,

Monteagudo

J

,

Sanz

C

,

Puig

L

,

Martínez

A

, et al.

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange

.

Ann Hematol

.

1995 Jun

;

70

(

6

):

319

–

23

.

.

https://doi.org/10.1056/NEJM199108083250604

8.

Rock

GA

,

Shumak

KH

,

Buskard

NA

,

Blanchette

VS

,

Kelton

JG

,

Nair

RC

, et al.

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

.

N Engl J Med

.

1991 Aug 8

;

325

(

6

):

393

–

7

.

.

https://doi.org/10.2147/JBM.S46458

9.

Blombery

P

,

Scully

M

.

Management of thrombotic thrombocytopenic purpura: current perspectives

.

J Blood Med

.

2014

;

5

:

15

–

23

.

.

https://doi.org/10.1182/blood-2016-10-709857

10.

Joly

BS

,

Coppo

P

,

Veyradier

A

.

Thrombotic thrombocytopenic purpura

.

Blood

.

2017 May 25

;

129

(

21

):

2836

–

46

.

.

https://doi.org/10.1097/CCM.0b013e31822e9d66

11.

Froissart

A

,

Buffet

M

,

Veyradier

A

,

Poullin

P

,

Provôt

F

,

Malot

S

, et al.

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

.

Crit Care Med

.

2012 Jan

;

40

(

1

):

104

–

11

.

.

https://doi.org/10.1111/ejh.12706

12.

Soucemarianadin

M

,

Benhamou

Y

,

Delmas

Y

,

Pichereau

C

,

Maury

E

,

Pène

F

, et al.

Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

.

Eur J Haematol

.

2016 Aug

;

97

(

2

):

183

–

91

.

.

https://doi.org/10.1046/j.1365-2141.1996.d01-1800.x

13.

Rock

G

,

Shumak

KH

,

Sutton

DM

,

Buskard

NA

,

Nair

RC

.

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

.

Br J Haematol

.

1996 Aug

;

94

(

2

):

383

–

6

.

.

https://doi.org/10.1111/trf.13229

14.

Toussaint-Hacquard

M

,

Coppo

P

,

Soudant

M

,

Chevreux

L

,

Mathieu-Nafissi

S

,

Lecompte

T

, et al.

Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study

.

Transfusion

.

2015 Oct

;

55

(

10

):

2445

–

51

.

.

https://doi.org/10.1111/j.1744-9987.2012.01112.x

15.

Nakae

H

,

Igarashi

T

,

Tajimi

K

.

Selective plasma exchange with dialysis in patients with acute liver failure

.

Ther Apher Dial

.

2012 Oct

;

16

(

5

):

467

–

71

.

.

https://doi.org/10.1046/j.1526-0968.2001.00380.x

16.

Nakae

H

,

Yonekawa

C

,

Wada

H

,

Asanuma

Y

,

Sato

T

,

Tanaka

H

.

Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure

.

Ther Apher

.

2001 Dec

;

5

(

6

):

471

–

5

.

.

https://doi.org/10.1046/j.1526-0968.2002.00464.x

17.

Nakae

H

,

Asanuma

Y

,

Tajimi

K

.

Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients

.

Ther Apher

.

2002 Dec

;

6

(

6

):

419

–

24

.

.

https://doi.org/10.1034/j.1600-0676.2002.00003.x

18.

Steiner

C

,

Mitzner

S

.

Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry

.

Liver

.

2002

;

22

(

Suppl 2

):

20

–

5

.

.

https://doi.org/10.1016/s0168-8278(03)00468-9

19.

Rifai

K

,

Ernst

T

,

Kretschmer

U

,

Bahr

MJ

,

Schneider

A

,

Hafer

C

, et al.

Prometheus: a new extracorporeal system for the treatment of liver failure

.

J Hepatol

.

2003 Dec

;

39

(

6

):

984

–

90

.

.

https://doi.org/10.1038/378088a0

20.

Okamura

H

,

Tsutsi

H

,

Komatsu

T

,

Yutsudo

M

,

Hakura

A

,

Tanimoto

T

, et al.

Cloning of a new cytokine that induces IFN-gamma production by T cells

.

Nature

.

1995 Nov 2

;

378

(

6552

):

88

–

91

.

.

https://doi.org/10.1258/0004563021901847

21.

Newman

DJ

.

Cystatin C

.

Ann Clin Biochem

.

2002 Mar

;

39

(

Pt 2

):

89

–

104

.

.

https://doi.org/10.1111/jgh.12440

22.

Komura

T

,

Taniguchi

T

,

Sakai

Y

,

Yamashita

T

,

Mizukoshi

E

,

Noda

T

, et al.

Efficacy of continuous plasma diafiltration therapy in critical patients with acute liver failure

.

J Gastroenterol Hepatol

.

2014 Apr

;

29

(

4

):

782

–

6

.

.

https://doi.org/10.1016/j.jhep.2015.08.018

23.

Larsen

FS

,

Schmidt

LE

,

Bernsmeier

C

,

Rasmussen

A

,

Isoniemi

H

,

Patel

VC

, et al.

High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial

.

J Hepatol

.

2016 Jan

;

64

(

1

):

69

–

78

.

.

https://doi.org/10.1016/j.jhep.2015.09.010

24.

Karvellas

CJ

,

Stravitz

RT

.

High volume plasma exchange in acute liver failure: dampening the inflammatory cascade?

J Hepatol

.

2016 Jan

;

64

(

1

):

10

–

2

.

.

25.

Larsen

FS

.

Reply to: “High volume plasma exchange in patients with acute liver failure.”

J Hepatol

.

2016 Sep

;

65

(

3

):

647

–

8

.

https://doi.org/10.1007/s12072-016-9703-z

26.

Maiwall

R

,

Moreau

R

.

Plasma exchange for acute on chronic liver failure: is there a light at the end of the tunnel?

Hepatol Int

.

2016 May

;

10

(

3

):

387

–

9

.

.

https://doi.org/10.1007/s12072-015-9667-4

27.

Yue-Meng

W

,

Yang

LH

,

Yang

JH

,

Xu

Y

,

Yang

J

,

Song

GB

.

The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure

.

Hepatol Int

.

2016 May

;

10

(

3

):

462

–

9

.

.

https://doi.org/10.1155/2018/4909742

28.

Ma

Y

,

Xu

Y

,

Chen

F

,

Wang

Y

,

Bai

L

,

Tang

H

.

Good tolerance of citrate accumulation due to plasma exchange among patients with acute-on-chronic liver failure: a prospective, observational study

.

Can J Gastroenterol Hepatol

.

2018

;

2018

:

4909742

.

.

https://doi.org/10.1016/s0140-6736(84)90819-5

29.

Osterman

PO

,

Fagius

J

,

Lundemo

G

,

Pihlstedt

P

,

Pirskanen

R

,

Sidén

A

, et al.

Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy

.

Lancet

.

1984 Dec 8

;

2

(

8415

):

1296

–

9

.

.

30.

Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome

.

Ann Neurol

.

1987 Dec

;

22

(

6

):

753

–

61

.

https://doi.org/10.1002/14651858.CD001798.pub3

31.

Chevret

S

,

Hughes

RA

,

Annane

D

.

Plasma exchange for Guillain-Barré syndrome

.

Cochrane Database Syst Rev

.

2017 Feb 27

;

2

(

2

):

CD001798

.

.

32.

Walsh

M

,

Merkel

PA

,

Peh

CA

,

Szpirt

WM

,

Puechal

X

,

Fujimoto

S

, et al.

Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis

.

N Engl J Med

.

2020 Feb 13

;

382

(

7

):

622

–

31

.

https://doi.org/10.1371/journal.pone.0196009

33.

Uechi

E

,

Okada

M

,

Fushimi

K

.

Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: a propensity-matched analysis using a nationwide administrative database

.

PLoS One

.

2018

;

13

(

4

):

e0196009

.

.

https://doi.org/10.1681/ASN.2007010090

34.

Jayne

DR

,

Gaskin

G

,

Rasmussen

N

,

Abramowicz

D

,

Ferrario

F

,

Guillevin

L

, et al.

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

.

J Am Soc Nephrol

.

2007 Jul

;

18

(

7

):

2180

–

8

.

.

https://doi.org/10.1016/j.jaut.2015.08.003

35.

de Luna

G

,

Chauveau

D

,

Aniort

J

,

Carron

PL

,

Gobert

P

,

Karras

A

, et al.

Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: data from the French Vasculitis Study Group

.

J Autoimmun

.

2015 Dec

;

65

:

49

–

55

.

.

https://doi.org/10.1186/s13054-020-2836-4

36.

Keith

P

,

Day

M

,

Perkins

L

,

Moyer

L

,

Hewitt

K

,

Wells

A

.

A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19

.

Crit Care

.

2020

;

24

(

1

):

128

.

Published 2020 Apr 2

.

.

https://doi.org/10.1016/j.ijantimicag.2020.105974

37.

Shi

H

,

Zhou

C

,

He

P

,

Huang

S

,

Duan

Y

,

Wang

X

, et al.

Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19

.

Int J Antimicrob Agents

.

2020 Apr 13

;

56

(

2

):

105974

.

Epub ahead of print

.

.

38.

Khamis

F

,

Al-Zakwani

I

,

Al Hashmi

S

,

Al Dowaiki

S

,

Al Bahrani

M

,

Pandak

N

, et al.

Therapeutic plasma exchange in adults with severe COVID-19 infection

.

Int J Infect Dis

.

2020 Jun 23

;

99

:

214

–

8

.

https://doi.org/10.1111/1744-9987.13536

39.

Turgutkaya

A

,

Yavaşoğlu

İ

,

Bolaman

Z

.

Application of plasmapheresis for Covid-19 patients

.

Ther Apher Dial

.

2020

.

Epub ahead of print

.

.

https://doi.org/10.1002/jca.20302

40.

Ward

DM

.

Conventional apheresis therapies: a review

.

J Clin Apher

.

2011

;

26

(

5

):

230

–

8

.

.

https://doi.org/10.1002/jca.21222

41.

Lee

G

,

Arepally

GM

.

Anticoagulation techniques in apheresis: from heparin to citrate and beyond

.

J Clin Apher

.

2012

;

27

(

3

):

117

–

25

.

.

42.

Betjes

MG

,

van Oosterom

D

,

van Agteren

M

,

van de Wetering

J

.

Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding

.

J Nephrol

.

2007 Sep–Oct

;

20

(

5

):

602

–

8

..

https://doi.org/10.1002/jca.20303

43.

Mokrzycki

MH

,

Balogun

RA

.

Therapeutic apheresis: a review of complications and recommendations for prevention and management

.

J Clin Apher

.

2011

;

26

(

5

):

243

–

8

.

.

https://doi.org/10.1002/jca.2920010406

44.

Grossman

L

,

Benny

WB

,

Buchanan

J

,

Erickson

RR

,

Buffaloe

GW

.

Clinical evaluation of a flat-plate membrane plasma exchange system

.

J Clin Apher

.

1983

;

1

(

4

):

225

–

37

.

.

45.

Golla

P

,

Hafer

C

,

Clajus

C

,

Schmidt

BMW

,

Kielstein

J

.

Membrane versus centrifuge based therapeutic plasma exchange: a clinical crossover comparison (Abstract)

.

NDT-Plus

.

2011

;

4

:

3

.